Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 07/1/13 → 06/30/14 |
Funding
- Genzyme Corporation: $94,185.00
Evaluating the risk of developing autoimmune diseases in Multiple Sclerosis Patients treated with Immunomodulatory therapies
- Weinstock-Guttman, Bianca (PI)
- Teter, Barbara (CoI)
Project: Research